Event | 14-15 Nov, 2022
Biomanufacturing World Summit
Accelerate process understanding and time-to-insight across your development and manufacturing lifecycle.
Join us at booth #21 at the Biomanufacturing World Summit in San Diego, USA.
Come meet our experts and learn how IDBS’ purpose-built software solutions address the data management challenges prominent across the BioPharma lifecycle and supply chain.
Our cloud-native and analytics-centric Polar BioProcess and Skyland PIMS platforms enable customers in development and manufacturing to efficiently and compliantly access critical data and insights to make faster, smarter decisions with greater confidence.
Skyland PIMS process information management system helps you improve understanding and control of your manufacturing process. PIMS serves as a centralized, persistent, dynamic knowledge platform allowing for more efficient gathering, analysis, reporting and sharing of clinical and commercial product, process, batch and patient data across internal and external teams, sites and partners. PIMS ensures data visibility and knowledge sharing critical to driving fast and effective scale-up and tech transfer and provides seamless operational transparency, thereby reducing costs and enabling compliance for all supply chain teams.
Polar BioProcess enables you to leverage historical data and knowledge to work smarter and faster in process development. See first-hand how Polar BioProcess digital workflows, integrated instrument and equipment connectors and advanced analytics enable you to accelerate BioPharma development and reduce the time to commercial readiness.
New in 2022 – We’re excited to debut Polar Insight embedded advanced analytics applications now available with Polar BioProcess:
- Cell Line Genealogy
- Bioreactor Comparison
- Design of Experiments (DoE)
- Multivariate analysis (MVA)
- and more…
Visit us at booth #21 to learn more and see a demo. We look forward to seeing you there!
Meet the team
Mark Isaacs, Vice President, Sales
Mark has 30 years of experience in senior-level, global business development focused on bringing innovative solutions to the life science industry. His expertise combines a technical understanding of manufacturing challenges with the commercial application of software solutions to maximize value realized from improved product quality and increased process understanding.
Mark holds a BSc in Natural Sciences/Chemical Engineering and a master’s degree in Chemical Engineering from the University of Cambridge. He is also a member of the International Society for Pharmaceutical Engineering and has served on several industry advisory boards.
Ken Forman, Senior Director, Product Strategy
Ken has over 28 years of experience and expertise in IT, Operations, and Product & Project Management focused in the software and pharmaceutical space. Prior to joining Skyland Analytics, Ken served as Director, Project Management, NAM at BIOVIA Dassault Systemes and held multiple director positions at Aegis Analytical. Previously, he was Director of IT at Rally Software Development, Director of Commercial Operations at Fischer Imaging and Director of IT at Allos Therapeutics and Genomica. In addition to his work accomplishments, he is a certified Scrum Master. Ken holds a BSc in Computer Science from Cal Poly and an MBA from the University of Colorado, Denver.
Sepideh Mohseni, Director of Sales PIMS, West Coast
Sep Mohseni has over 10 years of experience bringing innovative solutions to the Pharmaceutical, Hospital, CDMO/CMO, Medical Device, and Analytical Testing industries.
Her expertise in identifying the right IT solutions to address diverse and complex challenges makes her a respected advisor in maximizing value and creating pathways to realize improved service, product quality and patient safety.
Prior to IDBS, Sep held roles at Spectra and Infinity Laboratories where she aligned with strategic partners and helped clients define a pathway forward to accelerate product launch and decrease risk in the pharmaceutical and biotech manufacturing process.
Michael Barnes, Lead Solutions Consultant
Multidisciplinary Bench Scientist having worked in various roles/companies, from isolating rare and underrepresented cancers at the Broad Institute, to automating cell-based toxicology assays in a CRO setting.
Prior to shifting to IDBS, Michael spent ~3 years in Pfizer’s BioProcess R&D Cell Line Development group, working to evaluate different vectors/expression systems and investigate phenotypic changes at a genotypic level.